New therapy targets Brain's 'Orienting' reflex to treat PTSD
NCT ID NCT04317820
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a therapy called Deep Brain Reorienting (DBR) for people with PTSD. DBR helps patients focus on physical tension linked to traumatic memories. 234 adults will be randomly assigned to either DBR or a waitlist, and researchers will measure changes in PTSD symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Deep Brain Reorienting (DBR) therapy
- What this could lead to
- If it works, this could offer a new, non-drug therapy to ease PTSD symptoms for many people.
- What could go wrong
- This is a relatively early study with a waitlist control, so results may be influenced by placebo or natural recovery. The therapy is also not widely available yet.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
London Health Sciences Centre - University Hospital
London, Ontario, N6A 5A5, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can six short writing sessions ease PTSD in underserved patients?
- Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?
- Could a surgeon's mental health impact your surgery outcome?
- Brain scans may guide psychedelics and magnetic pulses to quell suicidal thoughts
- Can online training equip therapists to tackle PTSD and addiction?
- Zapping the brain with microcurrents may curb cravings — a trial puts it to the test